ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American and TASE: BTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced it is ...

That’s the first line of questions that Brian Culley—CEO at Lineage Cell Therapeutics, a clinical-stage biotechnology company developing cell therapies with headquarters in San Diego ...